Rockwell Medical (RMTI) Other Working Capital Changes (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Other Working Capital Changes came in at -$306000.0 in Q1 2026, up 35.58% YoY from -$225698.8 in Q1 2025, and down 191.89% on a QoQ basis from $333000.0 in Q3 2025.
Rockwell Medical (RMTI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 10 years of Other Working Capital Changes data on file, last reported at -$306000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 35.58% year-over-year to -$306000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 142.86% YoY) and the FY2025 annual result came in at -$475000.0, down 932.61% from the prior year.
- Other Working Capital Changes declined to -$306000.0 in Q1 2026, from $333000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q4 2022 to a low of -$4.5 million in Q2 2022.
- A 5-year average of -$69470.6 and a median of -$378000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 333.03% — and 2024, when it jumped 273.98%.
- Tracing RMTI's Other Working Capital Changes over 5 years: stood at -$2.4 million in 2022, then declined by 13.65% to -$2.7 million in 2023, then surged by 99.56% to -$12000.0 in 2024, then soared by 2875.0% to $333000.0 in 2025, then slumped by 191.89% to -$306000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$306000.0 (Q1 2026), $333000.0 (Q3 2025), and -$333000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -732,000.00 |
| Jun 30, 2026 | -732,000.00 |
| Jun 30, 2026 | -732,000.00 |
| Mar 31, 2026 | -426,000.00 |
| Mar 31, 2026 | -426,000.00 |
| Mar 31, 2026 | -426,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2024 | 167,000.00 |